| 标题 |
Results of a registrational Phase 2 study of lisaftoclax monotherapy for treatment of patients with Relapsed/Refractory chronic lymphocytic leukemia/small lymphocytic lymphoma who had failed Bruton tyrosine kinase inhibitors |
| 备注 |
需要Zhou KS等2025 ASH Abstract 88口头报告的原始幻灯PDF,含完整研究图表。不要仅会议摘要PDF,不要新闻稿或网页重排稿。
💡 该求助存在备注,如果存在信息冲突,请以备注为准
|
| 网址 | |
| DOI |
10.1182/blood-2025-88
doi
|
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)